Old Web
English
Sign In
Acemap
>
authorDetail
>
Sarah C. Riser
Sarah C. Riser
Rosalind Franklin University of Medicine and Science
Endogeny
Fibrosis
Extracellular matrix
Immunology
CTGF
3
Papers
139
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CCN3/CCN2 regulation and the fibrosis of diabetic renal disease
2010
Journal of Cell Communication and Signaling
Bruce L. Riser
Feridoon Najmabadi
Bernard Perbal
Jo Ann Rambow
Melisa L. Riser
Ernest J. Sukowski
Herman Yeger
Sarah C. Riser
Darryl R. Peterson
Show All
Source
Cite
Save
Citations (37)
CCN3 (NOV): A Negative Regulator of CCN2 (CTGF) Activity and an Endogenous Inhibitor of Fibrosis in Experimental Diabetic Nephropathy
2010
Bruce L. Riser
Feridoon Najmabadi
Bernard Perbal
Jo Ann Rambow
Melisa L. Riser
Ernest J. Sukowski
Herman Yeger
Sarah C. Riser
Darryl R. Peterson
Show All
Source
Cite
Save
Citations (0)
CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
2009
American Journal of Pathology
Bruce L. Riser
Feridoon Najmabadi
Bernard Perbal
Darryl R. Peterson
Jo Ann Rambow
Melisa L. Riser
Ernest J. Sukowski
Herman Yeger
Sarah C. Riser
Show All
Source
Cite
Save
Citations (102)
1